The hospitals and outpatient care centers market is projected to reach $5856.89 billion by 2030, growing at 4.3% CAGR, driven by outpatient care adoption, specialty clinics, and accessible healthcare services.
Read More
Global Polyetheretherketone (PEEK) Implants Industry Trends and Market Growth Forecast for 2026–2030
Polyetheretherketone implants market to reach $2.29 bn by 2030 at 8.1% CAGR, driven by rising orthopedic surgeries & advancements in patient-specific implants.
Read More
Polyether Ether Ketone interbody devices market to reach $2.74 bn by 2030 at 7.3% CAGR, driven by rise in spinal disorders & advanced surgical techniques.
Read More
Global Point-Of-Care Molecular Diagnostics market size is expected to reach $7.91 billion by 2030 at 14.7%, rising respiratory infections drive demand for point-of-care molecular diagnostics
Read More
Global Fibromyalgia Treatment market size is expected to reach $3.67 billion by 2030 at 5%, segmented as by symptomatic treatment, pain relievers, antidepressants, anti-seizure medications, sleep aids, physical therapy
Read More
Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment market size is expected to reach $0.76 Billion by 2030 at 8.8%, rise in gene therapy adoption driving growth of the market due to advancements in genetic research and regulatory support
Read More
Global Fibrocystic Breast Condition market size is expected to reach $9.41 Billion by 2030 at 5.8%, rising prevalence of breast cancer driving the growth of the market due to increasing health concerns and risk awareness
Read More
The fibroblast growth factors (FGFs) market is projected to reach $6.37 billion by 2030, growing at a 9.1% CAGR, driven by targeted therapies, biologics manufacturing, and regenerative medicine.
Read More
The fibroblast cells market is set to reach $1.18 billion by 2030, growing at a 9.3% CAGR, driven by cell therapy investment, regenerative medicine, and drug screening demand.
Read More
The fertility treatments market is projected to reach $29.7 billion by 2030, growing at 8.7% CAGR, driven by advanced fertility drugs, personalized protocols, and rising fertility tourism.
Read More